Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v20-FR | Version v5-EN | |
---|---|---|
Language | French | English |
Date Updated | 2024-04-11 | 2021-10-26 |
Drug Identification Number | 02160773 | 02160773 |
Brand name | DIOFLUOR STRIPS | DIOFLUOR STRIPS |
Common or Proper name | DIOFLUOR STRIPS | DIOFLUOR STRIPS |
Company Name | DIOPTIC PHARMACEUTICALS INC | DIOPTIC PHARMACEUTICALS INC |
Ingredients | FLUORESCEIN SODIUM | FLUORESCEIN SODIUM |
Strength(s) | 1MG | 1MG |
Dosage form(s) | STRIP | STRIP |
Route of administration | OPHTHALMIC OPHTHALMIC | OPHTHALMIC OPHTHALMIC |
Packaging size | 100 strip/box | 100 strip/box |
ATC code | S01JA | S01JA |
ATC description | DIAGNOSTICAGENTS | DIAGNOSTICAGENTS |
Reason for shortage | Disruption of the manufacture of the drug. | Shortage of an active ingredient. |
Anticipated start date | 2020-12-01 | 2020-12-01 |
Actual start date | 2021-03-22 | 2021-03-22 |
Estimated end date | 2025-04-30 | 2021-12-15 |
Actual end date | ||
Shortage status | Actual shortage | Actual shortage |
Tier 3 Status | No | No |
Company comments | Contract manufacturer need to qualify new API | Pervious inventory from approved API has been depleted. The new API site change require Health Canada submission and approval. |
Health Canada comments |